Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Key Intermed is a Brazilian pharmaceutical company specializing in the development, manufacturing, and distribution of high-complexity medicines. The company focuses on therapeutic areas such as oncology, hematology, nephrology, and rare diseases, providing both branded and generic pharmaceutical products. Key Intermed operates with a strong emphasis on the Brazilian institutional market, supplying hospitals and government health programs. Their portfolio includes a range of injectable and oral medications designed to treat chronic and life-threatening conditions. The company maintains modern manufacturing facilities compliant with international quality standards to ensure the safety and efficacy of its treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Key Intermed.